Ayoub J - Search Results

1

Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.

von Pawel J, von Roemeling R, Gatzemeier U, Boyer M, Elisson LO, Clark P, Talbot D, Rey A, Butler TW, Hirsh V, Olver I, Bergman B, Ayoub J, Richardson G, Dunlop D, Arcenas A, Vescio R, Viallet J, Treat J. von Pawel J, et al. Among authors: ayoub j. J Clin Oncol. 2000 Mar;18(6):1351-9. doi: 10.1200/JCO.2000.18.6.1351. J Clin Oncol. 2000. PMID: 10715308 Clinical Trial.

2

Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer.

Viallet J, Ayoub J, Rousseau P, Souhami L, Hohneker J, Shepherd F. Viallet J, et al. Among authors: ayoub j. Semin Oncol. 1994 Oct;21(5 Suppl 10):64-71; discussion 71-2. Semin Oncol. 1994. PMID: 7973771 Review.

3

Tallimustine is inactive in patients with previously treated small cell lung cancer. A phase II trial of the National Cancer Institute of Canada Clinical Trials Group.

Viallet J, Stewart D, Shepherd F, Ayoub J, Cormier Y, DiPietro N, Steward W. Viallet J, et al. Among authors: ayoub j. Lung Cancer. 1996 Nov;15(3):367-73. doi: 10.1016/0169-5002(95)00600-1. Lung Cancer. 1996. PMID: 8959681 Clinical Trial.

4

Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma: a phase II multicenter trial.

Hirsh V, Langleben A, Ayoub J, Cormier Y, Pintos J, Iglésias JL. Hirsh V, et al. Among authors: ayoub j. Cancer. 2001 Aug 15;92(4):830-5. doi: 10.1002/1097-0142(20010815)92:4<830::aid-cncr1389>3.0.co;2-c. Cancer. 2001. PMID: 11550154 Clinical Trial.

5

Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.

Hirsh V, Soulieres D, Duclos M, Faria S, Del Vecchio P, Ofiara L, Ayoub JP, Charpentier D, Gruber J, Portelance L, Souhami L. Hirsh V, et al. Among authors: ayoub jp. J Thorac Oncol. 2007 Oct;2(10):927-32. doi: 10.1097/JTO.0b013e3181560b92. J Thorac Oncol. 2007. PMID: 17909355 Free article. Clinical Trial.

6

A phase I/II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated irradiation for patients with inoperable nonsmall cell lung carcinoma.

Viallet J, Brassard MA, Souhami L, Ayoub J, Del Vecchio P, Kreisman H, Guerra J, Gruber J, Langleben A, Hohneker J, Rousseau P. Viallet J, et al. Among authors: ayoub j. Cancer. 1999 Jun 15;85(12):2562-9. Cancer. 1999. PMID: 10375103 Clinical Trial.

7

Phase II trial of 13-cis-retinoic acid plus interferon alpha in non-small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

Arnold A, Ayoub J, Douglas L, Hoogendoorn P, Skingley L, Gelmon K, Hirsh V, Eisenhauer E. Arnold A, et al. Among authors: ayoub j. J Natl Cancer Inst. 1994 Feb 16;86(4):306-9. doi: 10.1093/jnci/86.4.306. J Natl Cancer Inst. 1994. PMID: 8158687 Clinical Trial. No abstract available.

8

Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.

Evans WK, Eisenhauer EA, Cormier Y, Ayoub J, Wierzbicki R, Laberge F, Shepherd FA. Evans WK, et al. Among authors: ayoub j. J Clin Oncol. 1990 Mar;8(3):390-5. doi: 10.1200/JCO.1990.8.3.390. J Clin Oncol. 1990. PMID: 2155309

9

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.

O'Shaughnessy J, Miles D, Vukelja S, Moiseyenko V, Ayoub JP, Cervantes G, Fumoleau P, Jones S, Lui WY, Mauriac L, Twelves C, Van Hazel G, Verma S, Leonard R. O'Shaughnessy J, et al. Among authors: ayoub jp. J Clin Oncol. 2002 Jun 15;20(12):2812-23. doi: 10.1200/JCO.2002.09.002. J Clin Oncol. 2002. PMID: 12065558 Clinical Trial.

10

Gemcitabine is an active new agent in previously untreated extensive small cell lung cancer (SCLC). A study of the National Cancer Institute of Canada Clinical Trials Group.

Cormier Y, Eisenhauer E, Muldal A, Gregg R, Ayoub J, Goss G, Stewart D, Tarasoff P, Wong D. Cormier Y, et al. Among authors: ayoub j. Ann Oncol. 1994 Mar;5(3):283-5. doi: 10.1093/oxfordjournals.annonc.a058808. Ann Oncol. 1994. PMID: 8186176 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters